Borosil Scientific Ltd Valuation Shifts Signal Renewed Price Attractiveness

Valuation Metrics: A Closer Look

Recent data reveals that Borosil Scientific’s P/E ratio of 29.41, while still elevated relative to some peers, has moderated sufficiently to shift its valuation grade from expensive to fair. This adjustment is significant given the company’s previous Sell rating, which was upgraded to Hold on 19 May 2026, reflecting improved market sentiment and valuation comfort.

The price-to-book value (P/BV) ratio currently sits at 2.84, indicating that the stock trades at nearly three times its book value. While this is above the typical industrial products sector average, it is not excessive given Borosil’s return on capital employed (ROCE) of 13.69% and return on equity (ROE) of 9.64%, which suggest efficient capital utilisation and moderate profitability.

Enterprise value to EBITDA (EV/EBITDA) stands at 18.07, a figure that is higher than some peers but consistent with the company’s growth prospects and operational scale. The EV to EBIT ratio of 26.16 further underscores the premium investors are willing to pay for earnings before interest and taxes, reflecting confidence in Borosil’s earnings quality and future cash flow generation.

Comparative Peer Analysis

When compared with key competitors in the industrial products sector, Borosil Scientific’s valuation appears more reasonable. For instance, Saint-Gobain Sekurit is classified as very expensive with a P/E of 21.53 and EV/EBITDA of 15.29, while Haldyn Glass is considered attractive with a P/E of 24.92 and a notably lower EV/EBITDA of 11.68. Empire Industries stands out as very attractive with a P/E of 14.72 and EV/EBITDA of 8.54, highlighting the range of valuation multiples within the sector.

Several peers such as Jai Mata Glass, FGP, and Triveni Glass are flagged as risky due to loss-making operations or extreme valuation metrics, underscoring Borosil’s relative stability despite its micro-cap status. Agarwal Toughened Glass, while not qualifying for a valuation grade, trades at a P/E of 14.57 and EV/EBITDA of 11.39, offering a contrasting valuation profile.

Price Performance and Market Context

Borosil Scientific’s stock price has demonstrated resilience and outperformance relative to the broader market. Over the past week, the stock surged 18.72%, vastly outperforming the Sensex which declined by 0.29%. The one-month return of 22.69% further emphasises this momentum, especially against the Sensex’s 5.16% decline during the same period.

Year-to-date, Borosil Scientific has delivered a 17.78% return, contrasting sharply with the Sensex’s negative 11.78% performance. Although the stock has slightly declined by 1.12% over the last year, it has outperformed the Sensex’s 7.86% loss, signalling relative strength amid broader market volatility.

The 52-week price range of ₹96.65 to ₹190.45 indicates significant price volatility, with the current price of ₹141.40 positioned closer to the mid-point, suggesting room for upside if valuation multiples expand or earnings growth accelerates.

Quality and Growth Considerations

Borosil Scientific’s PEG ratio of 0.96 is noteworthy, indicating that the stock’s price-to-earnings ratio is nearly in line with its earnings growth rate, a sign of fair valuation relative to growth expectations. This contrasts with some peers like Haldyn Glass, which has a PEG of 2.29, suggesting overvaluation relative to growth, and Saint-Gobain Sekurit’s PEG of 0.79, which is lower but accompanied by a very expensive valuation grade.

The company’s ROCE of 13.69% and ROE of 9.64% reflect moderate but stable profitability, which supports the current valuation. The absence of dividend yield data suggests reinvestment of earnings into growth or operational needs, a common trait in industrial product companies focused on expansion and innovation.

Valuation Grade Upgrade and Market Implications

The upgrade from a Sell to Hold rating on 19 May 2026, accompanied by a Mojo Score of 67.0 and a Hold grade, signals a cautious but positive reassessment of Borosil Scientific’s investment case. The micro-cap classification highlights the stock’s smaller market capitalisation, which can entail higher volatility but also greater potential for price appreciation if fundamentals continue to improve.

Investors should note that while the valuation has become more attractive, the stock’s price remains sensitive to broader market movements and sector-specific dynamics. The industrial products sector often experiences cyclical fluctuations, and Borosil’s valuation multiples should be monitored in conjunction with earnings updates and macroeconomic indicators.

Investor Takeaway

For investors analysing Borosil Scientific Ltd, the recent valuation shift from expensive to fair offers a more compelling entry point, especially given the company’s solid operational metrics and relative outperformance against the Sensex. The P/E ratio of 29.41, while above some peers, is justified by the company’s growth prospects and efficiency ratios.

However, the micro-cap status and sector cyclicality warrant a measured approach. Investors should weigh Borosil’s valuation alongside its earnings trajectory and broader market conditions. The Hold rating and Mojo Score of 67.0 reflect this balanced outlook, suggesting that while the stock is no longer overvalued, it may not yet be a strong buy without further fundamental improvements.

In summary, Borosil Scientific Ltd’s valuation realignment enhances its price attractiveness, making it a stock worthy of consideration for investors seeking exposure to the industrial products sector with a moderate risk appetite.

Only Rs. 20,999 - Get MojoOne + Stock of the Week for 3 Years Get 71% Off →